Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celera Genomics Teams With GE To Develop Cancer Imaging Agents

This article was originally published in The Gray Sheet

Executive Summary

GE Global Research will assume responsibility for the regulation and manufacture of imaging agents to be jointly developed with Celera Genomics

You may also be interested in...



People In Brief

FDA external relations: Agency names Mayer, Brown, Rowe & Maw attorney Sheila Walcoff to succeed Peter Pitts as associate commissioner for external relations (1"The Gray Sheet" June 28, 2004, p. 4). In her new role, Walcoff will advise Acting Commissioner Lester Crawford on legal policy and program direction for FDA's interactions with stakeholders and other external audiences, as well as supervise the agency's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues and the Advisory Committee Oversight and Management Staff. Lawrence Bachorik, who had been filling in for Pitts, will return to his role as FDA assistant commissioner for public affairs...

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.

UsernamePublicRestriction

Register

MT020570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel